Outcomes on anti-VEGFR-2/paclitaxel treatment after progression on immune checkpoint inhibition in patients with metastatic gastroesophageal adenocarcinoma.

Saved in:
Bibliographic Details
Title: Outcomes on anti-VEGFR-2/paclitaxel treatment after progression on immune checkpoint inhibition in patients with metastatic gastroesophageal adenocarcinoma.
Authors: Kankeu Fonkoua LA; Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA.; Department of Hematology, Mayo Clinic, Rochester, Minnesota, USA., Chakrabarti S; Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA.; Department of Oncology, Medical College of Wisconsin, Wauwatosa, Wisconsin, USA., Sonbol MB; Department of Oncology, Mayo Clinic, Phoenix, Arizona, USA., Kasi PM; Department of Oncology, Mayo Clinic, Jacksonville, Florida, USA.; Department of Oncology, University of Iowa, Iowa City, Iowa, USA., Starr JS; Department of Oncology, Mayo Clinic, Jacksonville, Florida, USA., Liu AJ; Department of Oncology, Mayo Clinic, Phoenix, Arizona, USA., Nevala WK; Department of Hematology, Mayo Clinic, Rochester, Minnesota, USA., Maus RL; Department of Immunology, Mayo Clinic, Rochester, Minnesota, USA., Bois MC; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA., Pitot HC; Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA., Chandrasekharan C; Department of Oncology, University of Iowa, Iowa City, Iowa, USA., Ross HJ; Department of Oncology, Mayo Clinic, Phoenix, Arizona, USA., Wu TT; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA., Graham RP; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA., Villasboas JC; Department of Hematology, Mayo Clinic, Rochester, Minnesota, USA.; Department of Immune Monitoring Core, Mayo Clinic, Rochester, Minnesota, USA., Weiss M; ThedaCare Cancer Care, Appleton, Wisconsin, USA., Foster NR; Department of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota, USA., Markovic SN; Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA.; Department of Immunology, Mayo Clinic, Rochester, Minnesota, USA., Dong H; Department of Immunology, Mayo Clinic, Rochester, Minnesota, USA.; Department of Urology, Mayo Clinic, Rochester, Minnesota, USA., Yoon HH; Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA.
Source: International journal of cancer [Int J Cancer] 2021 Jul 15; Vol. 149 (2), pp. 378-386. Date of Electronic Publication: 2021 Mar 26.
Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural
Journal Info: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1097-0215
DOI:10.1002/ijc.33559